Wet AMD 4 Symposium

Related

• 

  Does Anti-VEGF Therapy Affect the Rate of Expansion of Geographic Atrophy in Patients with Neovascular AMD Managed by a Treat-Extend-Stop Protocol?

  Sean David Adrean, MD, FAAO, FASRS

  On Demand Cases, Courses, and Papers

  2019

• 

  Episode 29: Anti-VEGF Levels in Breast Milk after Intravitreal Injections- Drs. Muni and Juncal

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

• 

  Abicipar Phase 2 MAPLE Trial Supports Improved Safety for Patients with nAMD Following a Modified Manufacturing Process

  Raj K. Maturi, MD

  Updates from the Field

  2019